US Stock Insider Trading | Doximity disclosed two insider transactions on March 12

robot
Abstract generation in progress

On March 12, 2026, Doximity (DOCS) disclosed two insider trading transactions. Executive Sitaram Siddharth sold 2,319 shares on March 10, 2026.

【Recent Insider Transactions】

Disclosure Date Position Name Transaction Date Buy/Sell Quantity Price per Share/USD Total Amount/USD
March 12, 2026 Executive Sitaram Siddharth February 10, 2026 Sell 2,282 27.88 $63.6k
March 12, 2026 Executive Sitaram Siddharth March 10, 2026 Sell 2,319 25.37 $58.8k
March 5, 2026 Director Wampler Kira Scherer March 3, 2026 Sell 2,000 26.00 $52k
February 18, 2026 Executive Sitaram Siddharth February 15, 2026 Sell 946 25.02 $23.7k
February 18, 2026 Shareholder with >10% stake Tangney Jeffrey February 15, 2026 Sell 8,243 25.02 $206.2k
February 18, 2026 Executive Bryson Anna February 15, 2026 Sell 11.4k 25.02 $284.8k
February 18, 2026 Executive Sitaram Siddharth February 15, 2026 Buy 384 21.27 $8,166.53
February 4, 2026 Director Wampler Kira Scherer February 2, 2026 Sell 2,000 37.33 $74.7k
January 6, 2026 Director Wampler Kira Scherer January 2, 2026 Sell 2,000 44.65 $89.3k
December 3, 2025 Director Wampler Kira Scherer December 1, 2025 Sell 2,000 50.71 $101.4k

【Company Profile】

Doximity, Inc. was incorporated in Delaware in April 2010. It is a leading digital platform for medical professionals in the United States. As of March 31, 2021, it had over 63.6k healthcare professional members, including all 50 states and over 80% of physicians in each medical specialty. The cloud-based platform provides tools specifically built for medical professionals, enabling them to collaborate with colleagues, coordinate patient care securely, conduct virtual patient visits, stay updated with the latest medical news and research, and manage their careers.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin